These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 12082693)

  • 41. Long-term management of venous thromboembolism: is there a role for low-intensity warfarin therapy?
    Eikelboom JW; Hankey GJ
    Med J Aust; 2003 Jul; 179(2):68-9. PubMed ID: 12864713
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The safety of dosing dalteparin based on actual body weight for the treatment of acute venous thromboembolism in obese patients.
    Al-Yaseen E; Wells PS; Anderson J; Martin J; Kovacs MJ
    J Thromb Haemost; 2005 Jan; 3(1):100-2. PubMed ID: 15634272
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Anticoagulant treatment audited in the south of Sweden. A well functioning practice--which can improve even more].
    Timberg I; Schedvin G; Svensson PJ
    Lakartidningen; 2012 Aug 8-21; 109(32-33):1411-3. PubMed ID: 22953429
    [No Abstract]   [Full Text] [Related]  

  • 44. [Secondary ambulatory prophylaxis of venous thromboembolism: outcome of patients who were lost to follow-up].
    Wawrzyńska L; Hajduk B; Kober J; Filipecki S
    Pneumonol Alergol Pol; 1998; 66(5-6):278-82. PubMed ID: 9857647
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [New discoveries in the treatment of deep venous thrombosis: length of the treatment is the target of international studies].
    Berntorp E
    Lakartidningen; 1999 Nov; 96(45):4892-4. PubMed ID: 10596525
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparison of the therapeutic dose of warfarin in HIV-infected and HIV-uninfected patients: a study of clinical practice.
    Jackson BS; Mokoena T
    BMJ Open; 2017 Feb; 7(2):e013709. PubMed ID: 28179414
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [How long should anticoagulants be administered in the therapy of the first episode of venous thromboembolism?].
    Mahé I
    Presse Med; 1999 Oct; 28(29):1580. PubMed ID: 10544710
    [No Abstract]   [Full Text] [Related]  

  • 48. Outpatient treatment of community acquired venous thromboembolism--the Christchurch experience.
    Heaton D; Han DY; Inder A
    N Z Med J; 2002 Jul; 115(1158):U105. PubMed ID: 12362180
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A retrospective survey on practice of oral anticoagulant therapy in patients with cardiovascular diseases].
    Katona A; Márk L
    Orv Hetil; 2004 Aug; 145(32):1643-7. PubMed ID: 15384862
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quality of anticoagulation care in patients discharged from a pharmacist-managed anticoagulation clinic after stabilization of warfarin therapy.
    Garwood CL; Dumo P; Baringhaus SN; Laban KM
    Pharmacotherapy; 2008 Jan; 28(1):20-6. PubMed ID: 18154470
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.
    Kearon C; Gent M; Hirsh J; Weitz J; Kovacs MJ; Anderson DR; Turpie AG; Green D; Ginsberg JS; Wells P; MacKinnon B; Julian JA
    N Engl J Med; 1999 Mar; 340(12):901-7. PubMed ID: 10089183
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Warfarin treatment of venous thromboembolism].
    Andersen IA; Hammerstrøm J
    Tidsskr Nor Laegeforen; 2002 Apr; 122(10):1012-6. PubMed ID: 12082693
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outpatient management of anticoagulation therapy.
    du Breuil AL; Umland EM
    Am Fam Physician; 2007 Apr; 75(7):1031-42. PubMed ID: 17427618
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Initiating warfarin therapy: 5 mg versus 10 mg.
    Eckhoff CD; Didomenico RJ; Shapiro NL
    Ann Pharmacother; 2004 Dec; 38(12):2115-21. PubMed ID: 15522981
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.